Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Miami, Florida 33181


Purpose:

The purpose of this study is to investigate the amount of metabolites of ATL-962 in the blood and to investigate the effect of ATL-962 on the amount of fat that is excreted in the faeces in subjects who are obese


Study summary:

Obesity is a significant and increasing clinical problem. There is a need for effective therapeutic agents to help people reduce weight. ATL-962 is a lipase inhibitor which could reduce the amount of fat absorbed from a person's diet, leading to weight reduction.


Criteria:

Inclusion Criteria: - Obese, otherwise-healthy subjects - Body mass index 30-45kg/m2 Exclusion Criteria: - Women who are pregnant or breast feeding - Any drug treatment within 2 weeks of commencement of dosing in this study


NCT ID:

NCT00148382


Primary Contact:

Principal Investigator
Lawrence Galitz
SFBCI


Backup Contact:

N/A


Location Contact:

Miami, Florida 33181
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.